Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial.

Journal: Alzheimer's research & therapy

Publication date: 2023

Journal: Alzheimer's research & therapy

Publication Year: 2023

Authors & Co-authors:  Dubois Bruno B López-Arrieta Jesús J Lipschitz Stanley S Doskas Triantafyllos T Spiru Luiza L Moroz Svitlana S Venger Olena O Vermersch Patrick P Moussy Alain A Mansfield Colin D CD